Sanner achieves over EUR 85 million sales record

Germany-based Sanner, an international manufacturer of pharmaceutical primary packaging and medical technology products, has completed a successful business year 2019, with a total turnover of just over EUR 85 million (approximately Rs 720 crore), company mentioned this in a press statement. Due to investments in new products and existing sites, Sanner is optimistic about the future despite the Corona crisis. With a group turnover of more than EUR 85 million (approximately Rs 720 crore), Sanner has set a new company record. The development in Europe was stable; slight increases were achieved in China. The company recorded an above-average growth of 25% in the US and even more than 30% in India. According to the company, the demand is particularly strong for products from the “Engineered Product Solutions” segment. Sanner offers diagnostic solutions such as rapid tests and pulmonary applications such as inhalers and customized primary packaging. “We will continue to expand our business in the coming years. This includes innovations in the existing Sanner product portfolio as well as investments in internal developments,” says Johannis…

Choose your subscription to read more